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Patients submitted to hemodialysis are at a high risk for healthcare-associated infections
(HAI).  Presently there are scarce data to allow benchmarking of HAI rates in developing coun-
tries.  Also, most studies focus only on bloodstream infections (BSI) or local access infections
(LAI).  Our study aimed to provide a wide overview of HAI epidemiology in a hemodialysis
unit  in southeastern Brazil. We  present data from prospective surveillance carried out from
March  2010 through May 2012. Rates were compared (mid-p exact test) and temporally ana-
lyzed  in Shewhart control charts for Poisson distributions. The overall incidence of BSI was
1.12  per 1000 access-days. The rate was higher for patients performing dialysis through cen-
tral  venous catheters (CVC), either temporary (RR = 13.35, 95% CI = 6.68–26.95) or permanent
(RR  = 2.10, 95% CI = 1.09–4.13), as compared to those with arteriovenous ﬁstula. Control charts
identiﬁed  a BSI outbreak caused by Pseudomonas aeruginosa in April 2010. LAI incidence was
3.80  per 1000 access-days. Incidence rates for other HAI (per 1000 patients-day) were  asfollows: upper respiratory infections, 1.72; pneumonia, 1.35; urinary tract infections, 1.25;
skin/soft  tissues infections, 0.93. The data point out to the usefulness of applying methods
commonly  used in hospital-based surveillance for hemodialysis units.
tation  of infection control protocols.
© 2013 Elsevier Editora Ltda. Este é um artigo Open Access sob a licença de CC BY-NC-NDatients with end-stage renal disease (ESRD) undergoing
emodialysis are especially prone to acquiring healthcare-
1ssociated infections (HAI). This is due to both the dialysis
rocedure and to the immune compromising effects of the
nderlying  disease.2 However, like all HAI, those happening in
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There is a substantial amount of literature on HAI in
hemodialysis units (HU) for outpatients.4,5 Most reports on
this  subject focus speciﬁcally on bloodstream infections (BSI)
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RR = 3.38; 95%CI = 1.89-6.30.
RR = 2.02; 95%CI = 0.09-11.34.
Fig. 1 – Graphic comparison (forest plot) of the incidence of
bloodstream  infections related to several vascular accesses,
using  arteriovenous ﬁstula as a reference category. Note.328  b r a z j i n f e c t d 
or local access infection (LAI).6,7 Also, the vast majority of
studies  were  conducted in developed countries.4 Since bench-
marking  is a useful tool for measuring the effectiveness of
infection  control policies, data on the incidence of HAIs in
hemodialysis  in developing countries are needed.
In 2011, the Brazilian Society of Nephrology estimated that
there  were  45,000 patients undergoing hemodialysis in Brazil.8
Approximately 91% of patients’ therapies were  supported by
the Brazilian Public Health System (“Sistema Único de Saúde”
–  SUS). Though there are governmental rules for collecting HAI
data  in HU, no public report is presently available.9 Our study
aimed  to contribute to the knowledge on this issue, presenting
and  analyzing data on the epidemiology of HAI in a HU in the
city  of Botucatu, São Paulo State, southeastern Brazil.
The  HU is afﬁliated to the Botucatu Medical School teaching
hospital. It is the reference for hemodialysis for an area com-
prising  500,000 inhabitants. Prospective active surveillance
of  HAIs has been carried out since March 2010. Our study
focuses  on data from March 2010 through May  2012. Surveil-
lance  methods included daily visits to the unit, inspection of
catheters  access sites and real-time review of medical charts.
We  also performed monitoring of microbiological results. The
HAI  deﬁnitions followed the Centers for Diseases Control and
Prevention  (CDC) guidelines.10 The incidence density of BSI
and  LAI was  expressed in infections per 1000 access-days.
Incidence was  calculated for groups using different vascular
accesses: temporary catheters; permanent catheters; grafts;
or  arteriovenous ﬁstulas. For all other HAIs, incidence was
expressed  in infections per 1000 patient-days.
Comparisons of groups were performed using the mid-p
exact  test in OpenEpi software (©Emory University, Atlanta,
USA).  Forest plot charts were  built in a free online applicative
(http://www.stattools.net/ForestPlot Pgm.php).
We also assessed the temporal behavior of those infections,
using  Shewhart control charts.11 Brieﬂy, we built charts based
on  the Poisson distribution (also known as u-charts). Monthly
incidence  rates were used. The mean rate (u) was calculated
for  the whole period with the following formula:
u = sum of monthly HAI cases
sum of monthly access days
The standard error (sigma) was  obtained for each month
with  the formula:
sigma = square root
(
u
monthly access days
)
Finally, we  deﬁned “upper warning limit” (UWL) and “upper
control  limit” (UCL) as two and three sigma values above
the  mean rate, respectively. Following guidelines proposed by
Sellick,11 we  deﬁned atypical occurrences based on the ﬁnding
of  one month’s incidence above the UCL or values above UWL
for  two consecutive months.
During  the study period, a total of 49,831 patient-days were
counted,  which was  equal to the sum of access-days. The
number  of access days for speciﬁc groups was: temporary
catheter, 2460; permanent catheter, 19,110; graft, 900; ﬁstula,
27,361.
The  pooled BSI incidence for the study period was 1.12
per  1000 access-days (95% conﬁdence interval [CI], 0.86–1.45).
The  incidence (per 1000 access-days) for access groups wasRR,  rate ratio; CI, conﬁdence interval.
as follows: temporary catheters, 7.32 (95% CI, 4.47–11.34); per-
manent  catheters, 1.15 (95% CI, 0.74–1.71); grafts, 1.11 (95%
CI,  0.06–5.48), and ﬁstula, 0.55 (95% CI, 0.32–0.88). The BSI
incidence was signiﬁcantly higher (p < 0.05) for both catheters
groups,  as compared to the ﬁstula group (Fig. 1). The most
frequent  agents of BSI (recovered from blood cultures) were:
Staphylococcus aureus (36.6%), coagulase-negative staphylo-
cocci  (CoNS; 20.0%), Klebsiella spp. (16.7%), and Pseudomonas
aeruginosa (15.0%). Other Gram-negative bacilli accounted for
13.3% of cases. The resistance pattern of those agents was
noteworthy. Among Gram-positive cocci, resistance to methi-
cillin  was  found in 72.7% of S. aureus and 100% of CoNS.
Gram-negative bacilli were also often multidrug-resistant.
Resistance to third generation cephalosporins was  found in
three out of ten Klebsiella spp. and in the two Escherichia coli
strains  causing BSI in the study period. On the other hand, P.
aeruginosa  resistance to carbapenems (11.1%) and ceftazidime
(22.2%)  was  low.
The  pooled LAI incidence was  3.80 (95% CI, 3.30–4.39) per
1000  access-days. The incidence was  signiﬁcantly higher for
patients  with permanent catheters (9.58; 95% CI, 8.26–11.04)
when  compared to those with temporary catheters (2.03,
95%CI,  0.66–4.74). LAI incidence for ﬁstulas was  0.07 (95% CI,
0.01–0.24)  per 1000 access-days. There was  no LAI in grafts in
the  study period.
Incidence rates for other HAI (per 1000 patients-day)
were as follows: upper respiratory infections, 1.72 (95% CI,
1.35–2.16);  pneumonia, 1.35 (95% CI, 0.73–1.97); urinary tract
infections  (UTI), 1.25 (95% CI, 0.94–1.93); skin/soft tissues
infections, 0.93 (95% CI, 0.67–1.26); other sites, 0.12 (95% CI,
0.04–0.27).  Gram-negative predominated among agents of UTI:
Klebsiella spp. (33.9%), E. coli (27.5%), Enterobacter (14.5%) and P.
aeruginosa  (14.5%). Two thirds of Klebsiella and E. coli isolates
produced  extended-spectrum beta-lactamases.
We used control charts to analyze temporal behavior of BSI
and  LAI (Fig. 2). The charts characterized an outbreak of BSI
caused  by P. aeruginosa, on April 2010, comprising seven cases,
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rig. 2 – Shewhart control charts for monthly incidence rates
ote. UWL, upper warning limit; UCL, upper control limit.
hich on investigation proved to be related to contamination
f  water supply. We  also detected a rise in the incidence of LAI
n  the end of the study period, concurrently with the hiring of
ew  nursing personnel.
There  are similarities between infections occurring in hos-
ital  wards  and those affecting outpatients on hemodialysis.
his  is particularly true for catheter related infections. In fact,
oth  BSI and LAI are similar to their nosocomial counter-
arts  in terms of etiology, pathogenesis, and prevention.12
t is somewhat surprising that epidemiological tools from
osocomial infection surveillance are rarely applied in
U.
Benchmarking is one of those valuables tools for infection
ontrol.13 The comparison of particular units with aggregate
ata  from multicenter surveillance provides a basis for self-
ssessment  and for establishing policies and goals. The most
omplete  data for benchmarking of hemodialysis-related
nfections were  reported by the CDC’s National Healthcare
afety Network (NHSN).13 NHSN data was  expressed in infec-
ions  per 100 patient-months. When we converted our data
o  that unit, BSI incidence values were  as follows: 3.5 (perma-
ent  catheter), 21.9 (temporary catheter), 3.3 (graft) and 1.7
ﬁstula).  The NHSN data for these groups are 4.2, 27.1, 0.9 and
.5,  respectively. Even though the incidence of catheter-related
SI  in our institution was  slightly lower than that reported by
SHN, it was  three times higher for patients using grafts and
stula.  On the other hand, our data on LAI related to NSHN
ncidence in the following proportions: temporary catheters,
8.8  (our HU)/5.1 (NHSN); permanent catheters, 6.9/1.7; graft,
/0.4;  ﬁstula, 0.2/0.2. Unfortunately, no standards for bench-
arking  are available for HU in Brazil.
Control charts are other important tools for HAI
urveillance.11 The follow-up of monthly rates allows
nfection control practitioners to assess tendencies and to
dentify  atypical situations (such as outbreaks). Control charts
ere  particularly helpful for infection control diagnosis and
olicy  planning in our HU in the study period. The ﬁnding of
typical  incidences for BSI and LAI supported a revision ofoodstream infections (A) and local access infections (B).
the water supply and a strategy for continuous education for
nurses  and nursing technicians.
Although  there are few reports on infection sites other
than  BSI and LAI, they are by no means negligible. Recent
studies have indicated hemodialysis units as sources of
healthcare-associated pneumonia.14,15 Kawasaki et al. found
that  hemodialysis-associated pneumonia (HDAP) differed
from  cases arising in the community in both etiology (with
predominance of Staphylococcus aureus) and severity (with high
case-fatality ratio).16 The rate of HDAP in our study (1.35 per
1000  patients-day) was  similar to that reported for nosocomial
pneumonia among adult patients not submitted to mechani-
cal  ventilation in a Brazilian hospital (which was  1.02 per 1000
patients-day).17 This suggests that the underlying disease and
exposure  to healthcare do not differ between dialysis units
and  noncritical hospital wards. Even though further studies
focusing  this issue are necessary, the extension of surveillance
for  HDAP and other infection sites (not related to vascular
devices) may  be useful for timely detection and appropriate
management of individual cases or outbreaks.
In conclusion, our study found that BSI and LAI and
endemic in our HU, with atypical peaks related to working
processes. Also, it allowed us to identify high incidence of
infections  in other sites, especially HDAP. Above all, our data
underscore  the usefulness of applying methods commonly
used  in hospital-based surveillance to assess the safety of
healthcare  for patients undergoing hemodialysis.
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